Clinical Trial Update: Safety Study of LiRIS in Interstitial Cystitis (IC) Patients [Phase 1]

View source ↗

Summary

Allergan completed a Phase 1 safety study evaluating LiRIS in patients with interstitial cystitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• LiRIS

Snippet

Sponsor: Allergan | Conditions: Interstitial Cystitis | Phase 1 | Status: COMPLETED